Australian University Rankings Guide

American Journal of Speech-Language Pathology (ERA Journal)

American Journal of Speech-Language Pathology is an ERA accredited research journal used as part of the evaluation of the ERA research rankings.

American Journal of Speech-Language Pathology issns are issn1: 1058-0360 issn2: 1558-9110.

The fields covered by American Journal of Speech-Language Pathology as part of the evaluation of Australian university research excellence are:

Clinical Sciences Research Rankings (Sub-Field)

Cognitive Sciences Research Rankings (Sub-Field)

Linguistics Research Rankings (Sub-Field)

Other ERA-accredited journals supporting the evaluation of the Clinical Sciences field include:

- Acta Anaesthesiologica Scandinavica: an international journal of anaesthesiology and intensive care pain and emergency medicine
- American Journal of Clinical Dermatology
- Bailliere's Best Practice and Research in Clinical Anaesthesiology
- Current Opinion in Lipidology
- Cytoskeleton
- Genome Medicine: medicine in the post-genomic era
- JAIDS: Journal of Acquired Immune Deficiency Syndromes
- Journal of Anaesthesiology Clinical Pharmacology
- Journal of Digestive Diseases
- Journal of Infant Child and Adolescent Psychotherapy
- Journal of the European Academy of Dermatology and Venereology
- Nature Reviews Endocrinology
- Physiotherapy Canada
- Scandinavian Journal of Urology and Nephrology
- Scoliosis and Spinal Disorders


ERA Research Rankings Submenu


- ERA 2018 Outcomes Research Rankings List

- ERA 2018 Research Rankings Analysis

- ERA 2018 Individual University Outcomes List

- ERA List of Research Fields Rankings

- ERA Journal Rankings 2018 List



Latest News and Updates:


- Top 10 Best Australian Universities

- Gender Balance Male-Female Ratio

- ERA 2018 Outcomes Research Rankings List

- University Bachelor Degree Completion Rates

- QS Employability Rankings Australian Universities

- ARWU World Rankings of Australian Universities

- Group of Eight (go8) World Rankings

Share This Page

  • Share on Facebook1
  • Share on Twitter2
  • Share on Linkedin3
  • Share on Reddit4